Cosentyx sales are being boosted by recent launches, including the hidradenitis suppurativa indication (HS) and the ...

France: In a recent pilot study, researchers are investigating the efficacy of phenolization as a treatment for sinus tracts ...

aPsoriasis Research and Treatment Center, Department of Dermatology, Venereology and Allergology and Institute of Medical Immunology, Charité – Universitätsmedizin Berlin, Corporate Member of Freie ...

With better early detection and personalized treatment strategies, the quality of life for patients with this chronic, often painful condition is improving. Recent Developments in Hidradenitis ...

Study Uncovers Potential New Target for Treatment of Chronic, Debilitating Skin Disease Nov. 21, 2024 — Hidradenitis suppurativa (HS) is an immune disease that affects up to 4% of the global ...

Fibromyalgia (FMS) and chronic fatigue syndrome (CFS), also called myalgic encephalomyelitis (ME/CFS), are chronic conditions that have similar symptoms. Both cause extreme tiredness, which could ...

InflaRx (NASDAQ:IFRX – Get Free Report) was the target of a large increase in short interest in January. As of January 15th, there was short interest totalling 248,900 shares, an increase of 15.0% ...

Swiss pharma giant Novartis AG NVS reported better-than-expected results for the fourth quarter of 2024. Core earnings ...

After hours: February 4 at 5:18:54 PM EST Loading Chart for SLRN ...

Head of Investor Relations Welcome to the Q4 and full year 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide 3. Here we have the ...